1Jemal A,Siegel R,Xu J,et el. Cancer statistics,2010 [J]. CA Cancer J Clin, 2010,60(5 ) : 277-300.
2Barrel DP. MieroRNAs: genomics,biogenesis, mechanism, and function[J]. Ce11,2004,116(2) :281-297.
3Thomson JM, Newman M, Parker JS, et ah Extensive post-transcrip- tional regulation of microRNAs and its implications for cancer[J]. Genes Dev, 2006,20(16) : 2202-2207.
4Lewis BP,Burge CB,Bartel DP. Conserved seed pairing, often flanked by adenosines indicates that thousands of human genes are microRNA targets[J]. Ce11,2005,120( 1 ) : 15-20.
5Liep J, Rabien A, Jung K. Feedback networks between microRNAs and epigenetic modifications in urological tumors [J]. Epigeneties, 2012,7(4) :315-325.
6Wu XR. Urothelial tumorigenesis: a tale of divergent pathways [J ]. Nat Rev Cancer, 2005,5 : 713-725.
7Neely LA,Rieger-Christ KM,Neto BS,et el. A microRNA expression ratio defining the invasive phenotype in bladder tumors [J]. Urol 0ncol,2010,28(1):39-48.
8Kim SM, Kang HW, Kim WT, et el. Cell-free microRNA-214 from urine as a biomarker for non-uuscle-invasive bladder cancer[J]. Korean J Urol, 2013,54( 11 ) :791-796.
9Han Y, Chen J, Zhao X, et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing [J]. PLoS One, 2011,6:e18286.
10Wang Y, Luo I-I, Li Y, et el. hsa-miR-96up-regulates MAP4K1 and.IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas [J ]. Mol Med Rep, 2012,5 (1):260- 265.
